Skip to main content

Initial low and moderate dose of hydroxyurea has a durable impact on primary stroke prevention in low-income settings.

Publication ,  Journal Article
Abdullahi, SU; Galadanci, NA; Bello-Manga, H; Ibrahim, UA; Jibir, BW; Yusuf, AH; Galadanci, JA; Rodeghier, M; DeBaun, MR
Published in: Blood Adv
March 24, 2026

Duke Scholars

Published In

Blood Adv

DOI

EISSN

2473-9537

Publication Date

March 24, 2026

Volume

10

Issue

6

Start / End Page

1964 / 1966

Location

United States

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Abdullahi, S. U., Galadanci, N. A., Bello-Manga, H., Ibrahim, U. A., Jibir, B. W., Yusuf, A. H., … DeBaun, M. R. (2026). Initial low and moderate dose of hydroxyurea has a durable impact on primary stroke prevention in low-income settings. Blood Adv, 10(6), 1964–1966. https://doi.org/10.1182/bloodadvances.2025018364
Abdullahi, Shehu U., Najibah A. Galadanci, Halima Bello-Manga, Umma A. Ibrahim, Binta W. Jibir, Abdulkadir H. Yusuf, Jamil A. Galadanci, Mark Rodeghier, and Michael R. DeBaun. “Initial low and moderate dose of hydroxyurea has a durable impact on primary stroke prevention in low-income settings.Blood Adv 10, no. 6 (March 24, 2026): 1964–66. https://doi.org/10.1182/bloodadvances.2025018364.
Abdullahi SU, Galadanci NA, Bello-Manga H, Ibrahim UA, Jibir BW, Yusuf AH, et al. Initial low and moderate dose of hydroxyurea has a durable impact on primary stroke prevention in low-income settings. Blood Adv. 2026 Mar 24;10(6):1964–6.
Abdullahi, Shehu U., et al. “Initial low and moderate dose of hydroxyurea has a durable impact on primary stroke prevention in low-income settings.Blood Adv, vol. 10, no. 6, Mar. 2026, pp. 1964–66. Pubmed, doi:10.1182/bloodadvances.2025018364.
Abdullahi SU, Galadanci NA, Bello-Manga H, Ibrahim UA, Jibir BW, Yusuf AH, Galadanci JA, Rodeghier M, DeBaun MR. Initial low and moderate dose of hydroxyurea has a durable impact on primary stroke prevention in low-income settings. Blood Adv. 2026 Mar 24;10(6):1964–1966.

Published In

Blood Adv

DOI

EISSN

2473-9537

Publication Date

March 24, 2026

Volume

10

Issue

6

Start / End Page

1964 / 1966

Location

United States

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology